10-14333260-G-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000475141.2(FRMD4A):c.-81-3077C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 151,770 control chromosomes in the GnomAD database, including 5,501 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.26   (  5501   hom.,  cov: 30) 
Consequence
 FRMD4A
ENST00000475141.2 intron
ENST00000475141.2 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.09  
Publications
3 publications found 
Genes affected
 FRMD4A  (HGNC:25491):  (FERM domain containing 4A) This gene encodes a FERM domain-containing protein that regulates epithelial cell polarity. It connects ADP ribosylation factor 6 (ARF6) with the Par protein complex, which regulates the remodeling of adherens junctions and linear actin cable formation during epithelial cell polarization. Polymorphisms in this gene are associated with Alzheimer's disease, and also with nicotine dependence. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015] 
FRMD4A Gene-Disease associations (from GenCC):
- severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.399  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|
Ensembl
Frequencies
GnomAD3 genomes  0.256  AC: 38889AN: 151652Hom.:  5506  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
38889
AN: 
151652
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.256  AC: 38897AN: 151770Hom.:  5501  Cov.: 30 AF XY:  0.261  AC XY: 19327AN XY: 74132 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
38897
AN: 
151770
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
19327
AN XY: 
74132
show subpopulations 
African (AFR) 
 AF: 
AC: 
5866
AN: 
41398
American (AMR) 
 AF: 
AC: 
4414
AN: 
15256
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1119
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2112
AN: 
5108
South Asian (SAS) 
 AF: 
AC: 
1414
AN: 
4796
European-Finnish (FIN) 
 AF: 
AC: 
3292
AN: 
10516
Middle Eastern (MID) 
 AF: 
AC: 
114
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
19702
AN: 
67914
Other (OTH) 
 AF: 
AC: 
635
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1419 
 2839 
 4258 
 5678 
 7097 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 412 
 824 
 1236 
 1648 
 2060 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1241
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.